News

Written by Carol Stonham MBE This article reflects the opinions of a healthcare professional. The views expressed are their own. The intended use for the NObreath® is as follows: The 2nd generation NObreath® is a breath nitric oxide (NO) test...

Small Intestinal Bacterial Overgrowth (SIBO) is a gastrointestinal condition where an abnormal number of bacteria is found in the small intestine. Whilst small amounts of bacteria are normal, higher levels can cause uncomfortable digestive issues. SIBO can impact nutritional absorption...

Almost 10 months after the National Institute for Health and Care Excellence (NICE), the British Thoracic Society (BTS), and the Scottish Intercollegiate Guidelines Network (SIGN) released an updated joint guideline for asthma care and management, a major milestone has been...

Tobacco kills more than 7 million people each year, including an estimated 1.6 million non-smokers exposed to second-hand smoke.1 It is estimated that tobacco costs the global economy more than $1.4 trillion a year in healthcare costs and lost productivity.2...

Demonstrating innovations in respiratory and allergy diagnostics with the NObreath® and Gastrolyzer® range. Bedfont® Scientific Ltd., an innovative leader in the medical breath analysis industry with almost 50 years of experience, is pleased to join thousands of healthcare experts at...

Bedfont® celebrates global expansion by delivering UK healthcare solutions to a growing global audience. Bedfont® Scientific Limited, an innovative MedTech company that specialises in designing and manufacturing medical breath analysis devices, is thrilled to have been shortlisted in the Export...